COMPOSICION FARMACEUTICA QUE COMPRENDE METFORMINA R-(+) LIPOATO Y UN INHIBIDOR DE LA ENZIMA DE CONVERSION DE ANGIOTENSINA (ACE); FORMULACION DE DOSIS UNITARIA; Y USO EN EL TRATAMIENTO DE LA DIABETES.

摘要

Disclosed are pharmaceutical compositions, methods, and kits comprising metformin R-(+) lipoate and an antihypertensive agent or a pharmaceutically acceptable salt, hydrate, solvate and prodrug derivative thereof for the treatment of Type 2 diabetic hyperglycemia and diabetic complications.